117 related articles for article (PubMed ID: 2451645)
1. Effect of deuterium oxide on leukotriene C4 generation in immunologically stimulated human leukocytes.
Mita H; Yui Y; Yasueda H; Shida T
Int Arch Allergy Appl Immunol; 1988; 85(4):422-7. PubMed ID: 2451645
[TBL] [Abstract][Full Text] [Related]
2. Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli.
Warner JA; Peters SP; Lichtenstein LM; Hubbard W; Yancey KB; Stevenson HC; Miller PJ; MacGlashan DW
J Leukoc Biol; 1989 Jun; 45(6):558-71. PubMed ID: 2470847
[TBL] [Abstract][Full Text] [Related]
3. Deuterium-oxide-induced histamine release from basophils of allergic subjects. I. Responsiveness to deuterium oxide requires an activation step.
Kazimierczak W; Plaut M; Knauer KA; Meier HL; Lichtenstein LM
Am Rev Respir Dis; 1984 Apr; 129(4):592-6. PubMed ID: 6201094
[TBL] [Abstract][Full Text] [Related]
4. Complement-mediated release of histamine from human basophils. III. Possible regulatory role of microtubules and microfilaments.
Grant JA; Dupree E; Thueson DO
J Allergy Clin Immunol; 1977 Nov; 60(5):306-11. PubMed ID: 72086
[TBL] [Abstract][Full Text] [Related]
5. Allergen induced histamine release and immunoreactive-leukotriene C4 generation from leukocytes in mite sensitive asthmatic patients.
Mita H; Yui Y; Yasueda H; Kajita T; Saito H; Shida T
Prostaglandins; 1986 May; 31(5):869-86. PubMed ID: 2425395
[TBL] [Abstract][Full Text] [Related]
6. Patients with severe atopic dermatitis have activated circulating basophils.
James JM; Kagey-Sobotka A; Sampson HA
J Allergy Clin Immunol; 1993 Jun; 91(6):1155-62. PubMed ID: 7685363
[TBL] [Abstract][Full Text] [Related]
7. Effect of deuterium oxide (D2O) on the IgE-mediated Ca2+ influx, arachidonic acid and histamine release in rat basophilic leukemia cells.
Urata C; Watanabe A; Ogawa Y; Takei N; Nomoto H; Mizobe M; Abe Y; Mano K; Urata S
Arerugi; 1989 Mar; 38(3):285-95. PubMed ID: 2473727
[TBL] [Abstract][Full Text] [Related]
8. The heterogeneity of human IgE exemplified by the passive transfer of D2O sensitivity.
MacDonald SM; White JM; Kagey-Sobotka A; MacGlashan DW; Lichtenstein LM
Clin Exp Allergy; 1991 Jan; 21(1):133-8. PubMed ID: 1708690
[TBL] [Abstract][Full Text] [Related]
9. Histamine release from human leukocytes: studies with deuterium oxide, colchicine, and cytochalasin B.
Gillespie E; Lichtenstein LM
J Clin Invest; 1972 Nov; 51(11):2941-7. PubMed ID: 4117007
[TBL] [Abstract][Full Text] [Related]
10. Complement-induced histamine release from human basophils. III. Effect of pharmacologic agents.
Hook WA; Siraganian RP
J Immunol; 1977 Feb; 118(2):679-84. PubMed ID: 65434
[TBL] [Abstract][Full Text] [Related]
11. Cord blood basophil releasability: evaluation of histamine release and leukotriene C4 generation.
Miadonna A; Leggieri E; Tedeschi A; Lorini M; Motta G; Lucci G; Froldi M; Marini A; Zanussi C
Int Arch Allergy Appl Immunol; 1988; 86(1):42-7. PubMed ID: 2453473
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by adenosine of histamine and leukotriene release from human basophils.
Peachell PT; Lichtenstein LM; Schleimer RP
Biochem Pharmacol; 1989 Jun; 38(11):1717-25. PubMed ID: 2472139
[TBL] [Abstract][Full Text] [Related]
13. [Effect of pranlukast on histamine release and leukotriene c4 (ltc4) generation from human peripheral basophils].
Ito R; Miura K; Odajima Y; Shimamura T
Arerugi; 2004 Jan; 53(1):19-23. PubMed ID: 14762327
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human basophil leukotriene release by antiinflammatory steroids.
Schleimer RP; Davidson DA; Peters SP; Lichtenstein LM
Int Arch Allergy Appl Immunol; 1985; 77(1-2):241-3. PubMed ID: 3874167
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.
Marone G; Columbo M; Galeone D; Guidi G; Kagey-Sobotka A; Lichtenstein LM
Agents Actions; 1986 Apr; 18(1-2):100-2. PubMed ID: 2425566
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
[TBL] [Abstract][Full Text] [Related]
17. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
18. Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc.
Marone G; Findlay SR; Lichtenstein LM
J Pharmacol Exp Ther; 1981 May; 217(2):292-8. PubMed ID: 6164779
[TBL] [Abstract][Full Text] [Related]
19. Basophil mediator release in atopic dermatitis.
Bull HA; Courtney PF; Bunker CB; Rustin MH; Pearce FL; Dowd PM
J Invest Dermatol; 1993 Mar; 100(3):305-9. PubMed ID: 7680056
[TBL] [Abstract][Full Text] [Related]
20. Extracellular signal-regulated kinases regulate leukotriene C4 generation, but not histamine release or IL-4 production from human basophils.
Miura K; Schroeder JT; Hubbard WC; MacGlashan DW
J Immunol; 1999 Apr; 162(7):4198-206. PubMed ID: 10201947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
